JP2016197112A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016197112A5 JP2016197112A5 JP2016118888A JP2016118888A JP2016197112A5 JP 2016197112 A5 JP2016197112 A5 JP 2016197112A5 JP 2016118888 A JP2016118888 A JP 2016118888A JP 2016118888 A JP2016118888 A JP 2016118888A JP 2016197112 A5 JP2016197112 A5 JP 2016197112A5
- Authority
- JP
- Japan
- Prior art keywords
- pkc
- isozyme
- peptide
- index
- level
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000003923 Protein Kinase C Human genes 0.000 claims 33
- 108090000315 Protein Kinase C Proteins 0.000 claims 33
- 108010044467 Isoenzymes Proteins 0.000 claims 31
- 210000004027 cell Anatomy 0.000 claims 17
- 108090000765 processed proteins & peptides Proteins 0.000 claims 17
- 208000024827 Alzheimer disease Diseases 0.000 claims 16
- 238000000034 method Methods 0.000 claims 16
- 230000002093 peripheral effect Effects 0.000 claims 7
- 150000001875 compounds Chemical class 0.000 claims 5
- 102000014458 Protein Kinase C-epsilon Human genes 0.000 claims 4
- 108010078137 Protein Kinase C-epsilon Proteins 0.000 claims 4
- 102000004169 proteins and genes Human genes 0.000 claims 4
- 108090000623 proteins and genes Proteins 0.000 claims 4
- 230000026731 phosphorylation Effects 0.000 claims 3
- 238000006366 phosphorylation reaction Methods 0.000 claims 3
- 102100024924 Protein kinase C alpha type Human genes 0.000 claims 2
- 101710109947 Protein kinase C alpha type Proteins 0.000 claims 2
- 102100037314 Protein kinase C gamma type Human genes 0.000 claims 2
- 101710144823 Protein kinase C gamma type Proteins 0.000 claims 2
- 210000000601 blood cell Anatomy 0.000 claims 2
- 230000002500 effect on skin Effects 0.000 claims 2
- 210000002950 fibroblast Anatomy 0.000 claims 2
- 150000002611 lead compounds Chemical class 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 210000004927 skin cell Anatomy 0.000 claims 2
- 239000012190 activator Substances 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 229940000406 drug candidate Drugs 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 238000012216 screening Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24836109P | 2009-10-02 | 2009-10-02 | |
| US61/248,361 | 2009-10-02 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012532353A Division JP6013184B2 (ja) | 2009-10-02 | 2010-10-01 | アルツハイマー病末梢細胞におけるｐｋｃアイソザイムプロセッシングの異常変化 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016197112A JP2016197112A (ja) | 2016-11-24 |
| JP2016197112A5 true JP2016197112A5 (cg-RX-API-DMAC7.html) | 2017-03-23 |
Family
ID=43302691
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012532353A Active JP6013184B2 (ja) | 2009-10-02 | 2010-10-01 | アルツハイマー病末梢細胞におけるｐｋｃアイソザイムプロセッシングの異常変化 |
| JP2016118888A Pending JP2016197112A (ja) | 2009-10-02 | 2016-06-15 | アルツハイマー病末梢細胞におけるｐｋｃアイソザイムプロセッシングの異常変化 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012532353A Active JP6013184B2 (ja) | 2009-10-02 | 2010-10-01 | アルツハイマー病末梢細胞におけるｐｋｃアイソザイムプロセッシングの異常変化 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20110212474A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2483695A2 (cg-RX-API-DMAC7.html) |
| JP (2) | JP6013184B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN102741696A (cg-RX-API-DMAC7.html) |
| BR (1) | BR112012007557A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2776498A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2011041670A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2906164A1 (en) * | 2013-03-15 | 2014-09-18 | Daniel L. Alkon | Methods for identifying neuroprotective pkc activators |
| CA2978740A1 (en) | 2015-03-06 | 2016-09-15 | Blanchette Rockefeller Neurosciences Institute | Methods for classifying populations including alzheimer's disease populations |
| US20190041404A1 (en) * | 2016-02-22 | 2019-02-07 | The West Virginia University Board Of Governors On Behalf Of West Virginia University | Diagnosing mild cognitive impairment (mci), predicting alzheimer's disease (ad) dementia onset, and screening and monitoring agents for treating mci or preventing dementia onset |
| US20180282784A1 (en) * | 2017-03-31 | 2018-10-04 | NeuroDiagnostics LLC | LYMPHOCYTE-BASED PKCe TEST FOR ALZHEIMER'S DISEASE |
| CN115078570B (zh) * | 2022-05-30 | 2024-05-28 | 郑州大学第一附属医院 | Tau蛋白639位硫氰酸氨基酸修饰在快速质谱法检测阿尔茨海默症中的应用 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6080784A (en) * | 1986-06-11 | 2000-06-27 | Procyon Pharmaceuticals, Inc. | Protein kinase C modulators N |
| US5242932A (en) * | 1991-12-17 | 1993-09-07 | The Rockefeller University | Treatment of amyloidosis associated with alzheimer disease |
| US5385915A (en) * | 1990-05-16 | 1995-01-31 | The Rockefeller University | Treatment of amyloidosis associated with Alzheimer disease using modulators of protein phosphorylation |
| US20030108956A1 (en) * | 1993-05-03 | 2003-06-12 | Alkon Daniel L. | Cell tests for Alzheimer's disease |
| US6107050A (en) * | 1993-05-03 | 2000-08-22 | The United States Of America As Represented By The Department Of Health And Human Services | Diagnostic test for alzheimers disease |
| US5976816A (en) * | 1993-05-03 | 1999-11-02 | The United States Of America As Represented By The Department Of Health And Human Services | Cell tests for alzheimer's disease |
| US7625697B2 (en) * | 1994-06-17 | 2009-12-01 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for constructing subarrays and subarrays made thereby |
| US6077686A (en) * | 1996-02-29 | 2000-06-20 | Mount Sinai Hospital Corporation | Shc proteins |
| WO2001027624A2 (en) * | 1999-10-08 | 2001-04-19 | Superarray, Inc. | Compositions and methods for detecting protein modification and enzymatic activity |
| AUPR215700A0 (en) * | 2000-12-19 | 2001-01-25 | Fujisawa Pharmaceutical Co., Ltd. | Carboxylic acid compound having cyclopropane ring |
| EP1358329A2 (en) * | 2001-02-06 | 2003-11-05 | Incyte Genomics, Inc. | Lipid-associated molecules |
| CN1549721B (zh) * | 2001-02-27 | 2012-03-07 | 布朗歇特洛克菲勒神经科学研究所 | 基于促分裂原活化的蛋白激酶的磷酸化诊断阿尔茨海默氏病 |
| US20040014678A1 (en) * | 2001-08-08 | 2004-01-22 | Antonella Favit | Prevention of beta-amyloid neurotoxicity by blockade of the ubiquitin-proteasome proteolytoc pathway |
| US7608406B2 (en) * | 2001-08-20 | 2009-10-27 | Biosite, Inc. | Diagnostic markers of stroke and cerebral injury and methods of use thereof |
| US6897014B2 (en) | 2002-02-15 | 2005-05-24 | Fuji Photo Film Co., Ltd. | Silver halide photographic light-sensitive material, photographic emulsion, and mercapto group-containing polymer compound used for them |
| ITMI20031098A1 (it) * | 2003-05-30 | 2004-11-30 | Indena Spa | Composti utili nella terapia del morbo di alzheimer e formulazioni che li contengono |
| KR100574017B1 (ko) | 2003-08-11 | 2006-04-26 | 삼성전자주식회사 | 잉크젯 프린터의 잉크 카트리지 |
| EP1883841A1 (en) | 2005-05-27 | 2008-02-06 | Carl Zeiss SMT AG | Optical scattering disk, use thereof, and wavefront measuring apparatus |
| CA2617003A1 (en) * | 2005-07-29 | 2007-02-08 | Blanchette Rockefeller Neurosciences Institute | Use of a pkc activator, alone or combined with a pkc inhibitor to enhance long term memory |
| WO2007044094A1 (en) * | 2005-10-11 | 2007-04-19 | Blanchette Rockefeller Neurosciences Institute | Alzheimer's disease-specific alterations of the erk1/erk2 phosphorylation ratio as alzheimer's disease-specific molecular biomarkers (adsmb) |
| US7595167B2 (en) | 2005-10-11 | 2009-09-29 | Blanchette Rockefeller Neurosciences Institute | Alzheimer's disease-specific alterations of the Erk1/Erk2 phosphorylation ratio |
| US20090029873A1 (en) * | 2005-10-11 | 2009-01-29 | Blanchette Rockefeller Neurosciences Institute | Alzheimer's Disease-Specific Alterations of the Erk1/Erk2 Phosphorylation Ratio-Alzheimer's Disease-Specific Molecular Biomarkers (Adsmb) |
| US9974832B2 (en) | 2007-02-09 | 2018-05-22 | Cognitive Research Enterprises, Inc. | Therapeutic effects of bryostatins, bryologs, and other related substances on head trauma-induced memory impairment and brain injury |
-
2010
- 2010-10-01 CN CN2010800551432A patent/CN102741696A/zh active Pending
- 2010-10-01 US US12/895,957 patent/US20110212474A1/en not_active Abandoned
- 2010-10-01 BR BR112012007557A patent/BR112012007557A2/pt not_active Application Discontinuation
- 2010-10-01 CA CA2776498A patent/CA2776498A1/en not_active Abandoned
- 2010-10-01 WO PCT/US2010/051112 patent/WO2011041670A2/en not_active Ceased
- 2010-10-01 EP EP10821325A patent/EP2483695A2/en not_active Withdrawn
- 2010-10-01 JP JP2012532353A patent/JP6013184B2/ja active Active
-
2016
- 2016-06-15 JP JP2016118888A patent/JP2016197112A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES3049209T3 (en) | Ecg-based cardiac ejection-fraction screening | |
| JP2016197112A5 (cg-RX-API-DMAC7.html) | ||
| JP6927212B2 (ja) | 軽度認知障害又はアルツハイマー型認知症の評価方法 | |
| Jiang et al. | MALDI-mass spectrometric imaging revealing hypoxia-driven lipids and proteins in a breast tumor model | |
| WO2022058980A1 (en) | Methylation data signatures of aging and methods of determining a methylation aging clock | |
| CN106537130A (zh) | 用于分析物检测的电化学传感器 | |
| Martin et al. | Evaluation of Salivary Transcriptome Markers for the Early Detection of Oral Squamous Cell Cancer in a Prospective Blinded Trial. | |
| US9708669B2 (en) | Method for detecting genes sensitive to low-level ionizing radiation | |
| Nijmeh et al. | Emerging biomarkers of lymphangioleiomyomatosis | |
| Nardi et al. | Prevalence and predictors of left ventricular hypertrophy in patients with hypertension and normal electrocardiogram | |
| Lee et al. | Corrected QT interval on the electrocardiogram after liver transplantation: Surrogate marker of poor clinical outcomes? | |
| Shaikh et al. | Arrhythmogenic Right Ventricular Cardiomyopathy: A Comprehensive Review | |
| Barth et al. | Transcriptome, proteome, and metabolome in dyssynchronous heart failure and CRT | |
| Mohammed et al. | Proteomic evolution from acute to post-COVID-19 conditions | |
| JP2012019784A5 (cg-RX-API-DMAC7.html) | ||
| Chang et al. | Early myocardial repolarization heterogeneity is detected by magnetocardiography in diabetic patients with cardiovascular risk factors | |
| Yap et al. | Longitudinal community-based study of QT interval and mortality in Southeast Asians | |
| CN110763844A (zh) | 基于指甲角蛋白片段及角蛋白的含量和分布检测心脑血管疾病发病风险产品的方法及其应用 | |
| Haratani et al. | MO36-4 A multi-institutional, single-arm phase II study of pembrolizumab plus amrubicin in relapsed small cell lung cancer | |
| Kornej et al. | Association between echocardiographic parameters and biomarkers in probands with atrial fibrillation and different PR interval lengths: Insight from the epidemiologic LIFE Adult Study | |
| Pham et al. | Comment on Kridin et al.—Considering both relative and absolute risk differences in infection risk between biologics classes in patients with psoriasis. | |
| JP2015503106A5 (cg-RX-API-DMAC7.html) | ||
| Shibata et al. | MO37-5 Efficacy of liquid biopsy testing for comprehensive cancer genome profiling in 88 cases | |
| Tachihara et al. | MO37-3 Is bronchoscopic cytology pellets useful for oncomine comprehensive assay?–from the samples submitted to LC-SCRUM | |
| Sedhai et al. | CARDIAC INJURY IN MODERATE AN PATIENTS: ROLE |